MAPT and Alzheimer disease: The trend of the changes between the phosphorylation of Tau protein, elevated expression of DAPK1 protein, and increased inflammatory factors was consistent, and this change should be further explored, as the results may provide new ideas and approaches for ASS as a potential candidate for AD treatment.